Pay in 4 interest-free payments of $7.34 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Adding in glucagon receptor agonist activity A clinically advanced molecule possessing glucagon receptor activity is the triple co-agonist retatrutide a single peptide molecule combining GLP-1, GIP and glucagon RA activity, delivered subcutaneously once weekly
GLP-1 receptor agonists (GLP-1-RA) were first developed for the treatment of type-2 diabetes, but have been recently approved for treatment of obesity
For timing expectations, see our how long retatrutide takes to work timeline
We are here to help you navigate the ups and downs of your transformation
US$ 24.11
US$ 28.85
US$ 25.37
US$ 28.20
US$ 29.15
